US-based Ingredion has acquired British food ingredients manufacturer Tate & Lyle in a deal valued at approximately £2.7 billion, according to company announcements. The all-cash offer of 615 pence per share represents a 64% premium over Tate & Lyle's share price before negotiations were revealed.. The acquisition will remove the 104-year-old FTSE 250 firm from the London Stock Exchange, continuing a trend of foreign takeovers of prominent British companies.

The 64% Premium That Sealed the Deal

Ingredion's final offer of 615 pence per share combines 595 pence in cash plus a 20 pence dividend, according to the official statement. This values Tate & Lyle at roughly £2.7 billion and marks a 64% premium over the stock's value before Ingredion publicly declared its interest two weeks ago. As the source reported, Tate & Lyle's shares surged by more than 45% when negotiations were first disclosed, and they climbed an additional 12.3% to 552 pence following the official announcement.

The premium reflects Ingredion's willingness to pay up for a company that had been under financial pressure,but it also underscores the broader pattern of foreign acquirers taking advantage of what many analysts deem undervalued UK stocks.

A Profit Warning and a 10% Decline: Tate & Lyle's Recent Struggles

Tate & Lyle had been grappling with headwinds long before the bid. In October, the company issued a profit warning, and in November it reported a 10% decline in first-half profits, as the source noted. Factors included subdued consumer demand, rising costs, and the growing prevalence of weight-loss pharmaceuticals that are reshaping the food industry. These challenges likely made the company a more willing acquisition target, even as Ingredion's chief executive Jim Zallie framed the merger as a way to better serve customers seeking healthier, affordable food products.

The company had already divested its European sugar operations—including the iconic Lyle's Golden Syrup brand—to American Sugar Refining in 2010, leaving it focused on specialty ingredients and sweeteners.

The £2.7 Billion Wave: A Growing List of Foreign Takeovers

Tate & Lyle's acquisition is far from an isolated event.. Just last week, Evoke, owner of the William Hill betting brand,agreed to a £243 million purchase by Greek gaming conglomerate Intralot, according to the source. Last month, laboratory testing firm Intertek endorsed a £9.4 billion takeover by Swedish private equity firm EQT. Other major deals in 2025 include the £9.9 billion acquisition of asset manager Schroders by US rival Nuveen, and the £8.1 billion purchase of Lloyd's of London insurer Beazley by Zurich Insurance. This spate of foreign takeovers has fueled debate in London's financial district about whether British companies are being sold too cheaply.

The trend raises brodaer questions about the UK's attractiveness as a public market and whether domestic firms are systematically undervalued.

What Remains Unknown: Regulatory Hurdles and Post-Merger Plans

The source did not detail any required regulatory approvals for the Ingredion-Tate & Lyle deal, nor did it specify changes to Tate & Lyle's operations or workforce. Ingredion's Jim Zallie spoke generally about the combined entity's capability to develop great-tasting, healthier food, but the companies have not released integration timelines or commitments to UK manufacturing sites. Unanswered questions include whether the deal will face antitrust scrutiny in key markets and how Ingredion will handle Tate & Lyle's existing supply chain relationships. shareholders have approved the deal, but the closure remains contingent on standard closing conditions.